Severe skeletal complications in Japanese patients with type 1 Gaucher disease

Journal of Inherited Metabolic Disease

Volumn 22, Issue 1, 1999, Pages 63-73

  Ida, H ^a   Rennert, O M ^b   Kato, S ^c   Ueda, T ^d   Oishi, K ^a   Maekawa, K ^a   Eto, Y ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c TOKAI UNIVERSITY   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME; GLUCOSYLCERAMIDASE;

ADOLESCENT; ARTICLE; AVASCULAR NECROSIS; BONE DISEASE; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL EXAMINATION; DETERIORATION; DISEASE SEVERITY; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; GENOTYPE; HIGH RISK PATIENT; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGIC FRACTURE; PHENOTYPE; RADIOLOGY; SPLENECTOMY;

ADOLESCENT; ADULT; BONE DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; GAUCHER DISEASE; HUMANS; INFANT; JAPAN; MALE; MIDDLE AGED;

EID: 0033035771     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005451300167     Document Type: Article

References (28)

1. Ashkenazi A, Zaizov R, Matoth Y (1986) Effect of splenectomy on destructive bone changes in children with chronic (type 1) Gaucher disease. Eur J Pediatr 145: 138-141.
2. Balicki D, Beutler E (1995) Gaucher disease. Medicine (Baltimore) 74: 305-323.
3. Belmatoug N, Billette de Villemeur T for the Comité d'Evaluation du Traitement par la Cérédase (1995) Skeletal response to enzyme replacement therapy of type 1 Gaucher disease: a preliminary report of the French experience. Semin Hematol 32 (3, supplement 1): 33-38.
4. Brady RO, Murray GJ, Barton NW (1994) Modifying exogenous glucocerebrosidase for effective replacement therapy in Gaucher disease. J Inher Metab Dis 17: 510-519.
5. Choy FYM, Humphries ML, Shi HP (1997) Identification of two novel and four uncommon missense mutations among Chinese Gaucher disease patients. Am J Med Genet 71: 172-178.
6. Elstein D, Hadas-Halpern I, Itzchaki M, Lahad A, Abrahamov A, Zimran A (1996) Effect of low-dose enzyme replacement therapy on bones in Gaucher disease patients with severe skeletal involvement. Blood Cells Mol Dis 22: 101-108.
7. Figueroa ML, Rosenbloom BE, Kay AC, et al (1992) A less costly regimen of alglucerase to treat Gaucher disease. N Engl J Med 327: 1632-1636.
8. Goldblatt J, Beighton P (1982) South African variants of Gaucher disease. In Desnick RJ, Gatt S, Grabowski GA, eds. Gaucher Disease: a Century of Delineation and Research. New York: Alan R. Liss, 95-106.
9. Goldblatt J, Sacks S, Beighton P (1978) The orthopedic aspects of Gaucher disease. Clin Orthop Rel Res 137: 208-214.
10. Hill SC, Parker CC, Brady RO, Barton NW (1993) MRI of multiple platyspondyly in Gaucher disease: response to enzyme replacement therapy. J Comput Assist Tomogr 17: 806-809.
11. Hollak CEM, Aerts JMFG, Goudsmit R, et al (1995) Individualised low-dose alglucerase therapy for type 1 Gaucher's disease. Lancet 345: 1474-1478.
12. Ida H, Iwasawa K, Kawame H, Rennert OM, Maekawa K, Eto Y (1995) Characteristics of gene mutations among 32 unrelated Japanese Gaucher disease patients: absence of the common Jewish 84GG and 1226G mutations. Hum Genet 95: 717-720.
13. Ida H, Rennert OM, Kawame H, Maekawa K, Eto Y (1997) Mutation prevalence among 47 unrelated Japanese patients with Gaucher disease: identification of four novel mutations. J Inher Metab Dis 20: 67-73.
14. Ida H, Rennert OM, Ito T, Maekawa K, Eto Y (1998) Type 1 Gaucher disease; phenotypic expression and natural history in Japanese patients. Blood Cells Mol Dis 24: 73-81.
15. Katz K, Cohen IJ, Ziv N, Grunebaum M, Zaizov R, Yosipovitch Z (1987) Fractures in children who have Gaucher disease. J Bone Joint Surg 69A: 1361-1370.
16. Kim JW, Liu BB, Lai MY, Ponce E, Grabowski GA (1996) Gaucher disease: identification of three new mutations in the Korean and Chinese (Taiwanese) populations. Hum Mutat 7: 214-218.
17. Lee RE (1982) The pathology of Gaucher disease. In Desnick RJ, Gatt S, Grabowski GA, eds. Gaucher Disease: a Century of Delineation and Research. New York: Alan R. Liss, 177-217.
18. Mankin HJ, Doppelt SH, Rosenberg AE, Barranger JA (1990) Metabolic bone disease in patients with Gaucher disease. In Avioli LV, Krane SM, eds. Metabolic Bone Disease and Clinically Related Disorders, 2nd edn. Philadelphia: WB Saunders, 730-752.
19. Pastures GM, Hermann G, Norton K, Desnick RJ (1995) Resolution of a proximal defect in type 1 Gaucher disease by enzyme replacement therapy. Pediatr Radiol 25: 486-487.
20. Pastures GM, Wallenstein S, Desnick RJ, Luckey MM (1996) Bone density in type 1 Gaucher disease. J Bone Miner Res 11: 1801-1807.
21. Ringdén O, Groth CG, Erikson A, Granqvist S, Månsson JE, Sparrelid E (1995) Ten years' experience of bone marrow transplantation for Gaucher disease. Transplantation 59: 864-870.
22. Rose JS, Grabowski GA, Barnett SH, Desnick RJ (1982) Accelerated skeletal deterioration after splenectomy in Gaucher type 1 disease. Am J Roentgenol 139: 1202-1204.
23. Rosenthal DI, Doppelt SH, Mankin HJ, et al (1995) Enzyme replacement therapy for Gaucher disease: skeletal responses to macrophage-targeted glucocerebrosidase. Pediatrics 96: 629-637.
24. Sibille A, Eng CM, Kim SJ, Pastures G, Grabowski GA (1993) Phenotype/genotype correlations in Gaucher disease type 1: clinical and therapeutic implications. Am J Hum Genet 52: 1094-1101.
25. Starer F, Sargent JD, Hobbs JR (1987) Regression of the radiological changes of Gaucher's disease following bone marrow transplantation. Br J Radiol 60: 1189-1195.
26. Stowens DW, Teitelbaum SL, Kahn AJ, Barranger JA (1985) Skeletal complications of Gaucher disease. Medicine (Baltimore) 64: 310-322.
27. Zevin S, Abrahamov A, Hadas-Halpern I, et al (1993) Adult-type Gaucher disease in children: genetic, clinical features and enzyme replacement therapy. Q J Med 86: 565-573.
28. Zimran A, Kay A, Saven A, Thurston D, Garver P, Beutler E (1992) Gaucher disease: clinical, laboratory, radiologic and genetic features in 53 patients. Medicine (Baltimore) 71: 337-353.